Affimed N.V. (AFMD)
NASDAQ: AFMD · Real-Time Price · USD
2.720
-0.280 (-9.33%)
At close: Nov 20, 2024, 4:00 PM
2.850
+0.130 (4.78%)
After-hours: Nov 20, 2024, 5:56 PM EST
Affimed Market Cap
Affimed has a market cap or net worth of $42.65 million as of November 21, 2024. Its market cap has decreased by -25.43% in one year.
Market Cap
42.65M
Enterprise Value
30.15M
1-Year Change
-25.43%
Ranking
Category
Stock Price
$2.72
Market Cap Chart
Since September 12, 2014, Affimed's market cap has decreased from $126.70M to $42.65M, a decrease of -66.34%. That is a compound annual growth rate of -10.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 44.60M | -52.20% |
| Dec 29, 2023 | 93.30M | -49.62% |
| Dec 30, 2022 | 185.20M | -65.86% |
| Dec 31, 2021 | 542.50M | 22.24% |
| Dec 31, 2020 | 443.80M | 159.38% |
| Dec 31, 2019 | 171.10M | 17.59% |
| Dec 31, 2018 | 145.50M | 236.81% |
| Dec 29, 2017 | 43.20M | -27.88% |
| Dec 30, 2016 | 59.90M | -64.93% |
| Dec 31, 2015 | 170.80M | 23.86% |
| Dec 31, 2014 | 137.90M | 8.84% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prelude Therapeutics | 51.84M |
| Lucid Diagnostics | 51.29M |
| Kronos Bio | 51.24M |
| vTv Therapeutics | 50.87M |
| Cytosorbents | 50.85M |
| BGM Group | 49.23M |
| Milestone Scientific | 49.10M |
| Protara Therapeutics | 47.65M |